Back
Blueprint Medicines Stock Predictions
Buy
59
BPMC
Blueprint Medicines
Last Price:
104.92
Seasonality Move:
13.7%
7 Day Trial
ALL ACCESS PASS
$
7
Blueprint Medicines Stock Forecast
- Over the next 52 weeks, Blueprint Medicines has on average historically risen by 43.6% based on the past 9 years of stock performance.
- Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Blueprint Medicines Stock Undervalued?
The current Blueprint Medicines [BPMC] share price is $104.96. The Score for BPMC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal. - BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Blueprint Medicines Stock Go Up Next Year?
- Over the next 52 weeks, Blueprint Medicines has on average historically risen by 43.6% based on the past 9 years of stock performance.
Blueprint Medicines Stock Rating
Buy
59
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines overpriced?
- Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Blueprint Medicines Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com
52-Week Data
52-Week High:
111.02
52-Week Low:
43.89
Prediction Charts
Market Cap:
6.57B
Price in USD:
104.96
Volume:
415.56K
Beta:
0.87
Technical Analysis
SMA50:
94.47
SMA100:
89.74
SMA200:
73.73
52-Wk Change:
92.73%
Stock Predictions
-
Is Blueprint Medicines stock public?
Yes, Blueprint Medicines is a publicly traded company. -
What is the Blueprint Medicines stock quote today?
The Blueprint Medicines stock price is 104.96 USD today. -
How to buy Blueprint Medicines stock online?
You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 91.45 | 91.39 | 93.37 | 90.75 |
May-1 | 91.44 | 94.86 | 96.41 | 90.85 |
May-2 | 103.88 | 107.00 | 110.16 | 100.91 |
May-3 | 109.82 | 107.19 | 110.93 | 106.07 |
May-6 | 107.93 | 106.25 | 108.51 | 105.48 |
May-7 | 105.99 | 108.67 | 109.41 | 103.31 |
May-8 | 107.50 | 108.78 | 109.15 | 106.48 |
May-9 | 109.00 | 108.49 | 109.87 | 108.00 |
May-10 | 108.71 | 106.70 | 109.02 | 106.01 |
May-13 | 109.16 | 108.05 | 109.48 | 106.01 |
May-14 | 109.53 | 105.46 | 111.02 | 105.27 |
May-15 | 107.88 | 106.79 | 108.75 | 106.09 |
May-16 | 106.66 | 106.64 | 107.69 | 105.81 |
May-17 | 107.00 | 104.96 | 107.17 | 103.23 |
Blueprint Medicines Earnings
Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.
Blueprint Medicines Forecast Revenue Growth
Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.